ppp2ca antibody Search Results


ppp2ca antibody / pp2a alpha  (NSJ Bioreagents)
99
NSJ Bioreagents ppp2ca antibody / pp2a alpha
Ppp2ca Antibody / Pp2a Alpha, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/PPP2CA+Antibody+%2F+PP2A+alpha/custom%40rq5853%4028947679
Average 99 stars, based on 1 article reviews
ppp2ca antibody / pp2a alpha - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
pp2ac  (Proteintech)
94
Proteintech pp2ac
Pp2ac, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/PPP2CA+Antibody/pm40579780-307-47-50
Average 94 stars, based on 1 article reviews
pp2ac - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
ppp2ca  (OriGene)
90
OriGene ppp2ca
Figure 5. NT activates AKT through suppression of <t>PPP2CA</t> by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).
Ppp2ca, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/PP2A-alpha+(PPP2CA)+Goat+Polyclonal+Antibody/pm21806946-23-39-42
Average 90 stars, based on 1 article reviews
ppp2ca - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ppp2ca b  (Atlas Antibodies)
85
Atlas Antibodies ppp2ca b
Figure 5. NT activates AKT through suppression of <t>PPP2CA</t> by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).
Ppp2ca B, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/Anti-PPP2CA/pmc04528246-588-13-32
Average 85 stars, based on 1 article reviews
ppp2ca b - by Bioz Stars, 2026-09
85/100 stars
  Buy from Supplier
anti-fas antibody cat# 05-338, clone zb4  (Merck KGaA)
90
Merck KGaA anti-fas antibody cat# 05-338, clone zb4
Figure 5. NT activates AKT through suppression of <t>PPP2CA</t> by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).
Anti Fas Antibody Cat# 05 338, Clone Zb4, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/antibody+anti+PPP2CA+Cat+++05+421/pmc08583435-196-24-30
Average 90 stars, based on 1 article reviews
anti-fas antibody cat# 05-338, clone zb4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pp2a c subunit  (Cusabio)
91
Cusabio pp2a c subunit
Figure 5. NT activates AKT through suppression of <t>PPP2CA</t> by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).
Pp2a C Subunit, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/Rabbit+anti-+PPP2CA+Polyclonal+Antibody/pm36916919-232-32-35
Average 91 stars, based on 1 article reviews
pp2a c subunit - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
anti ppp2ca  (Aviva Systems)
94
Aviva Systems anti ppp2ca
Figure 5. NT activates AKT through suppression of <t>PPP2CA</t> by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).
Anti Ppp2ca, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ppp2ca+antibody/PPP2CA+Antibody+(OALA02971)/pm40139147-92-17-5
Average 94 stars, based on 1 article reviews
anti ppp2ca - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
ppp2ca polyclonal antibody, hrp conjugated  (EpiGentek)
N/A
   Buy from Supplier
ppp2ca polyclonal antibody, fitc conjugated  (EpiGentek)
N/A
   Buy from Supplier
anti-ppp2ca (aa 1-231) polyclonal antibody  (Creative BioMart)
N/A
PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Cooperates with SGOL2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By
   Buy from Supplier
ppp2ca antibody  (ProSci Incorporated)
N/A
PPP2CA Antibody raised in Rabbit validated in WB in Mouse.
   Buy from Supplier

Image Search Results


Figure 5. NT activates AKT through suppression of PPP2CA by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).

Journal: Gastroenterology

Article Title: Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

doi: 10.1053/j.gastro.2011.07.038

Figure Lengend Snippet: Figure 5. NT activates AKT through suppression of PPP2CA by direct interaction with miR-155. (A) miR-155 binding sites in 3=UTRs of PPP2CA predicted by Lever algorithm analysis. (B) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells transfected with as-miR-155 (100 nmol/L) or as-miR-155 (100 nmol/L) for 24 hours. (C) Luciferase activity of the PPP2CA 3=UTRs in HCT116 and DLD1 cells treated with NT (100 nmol/L). (D) PPP2CA and -actin protein levels, assessed by Western blot, in NT-treated (100 nmol/L, 6 h) HCT116 and DLD1 cells. (E) AKT phosphorylation (S473) levels, assessed by enzyme-linked immunosorbent assay, in HCT116 and DLD1 cells transfected with miR-155 (100 nmol/L) or si-PPP2CA (100 nmol/L) for 24 hours. (F) NF-B/p65 activity, assessed by enzyme-linked immunosorbent assay, in HCT cells transfected with NT (100 nmol/L) and as-miR-NC (100 nmol/L), as-miR-21 (100 nmol/L), as-miR-155 (100 nmol/L), or with 10 nmol/L of an AKT pharmacologic inhibitor (MK-2206).

Article Snippet: Materials and Methods Antibodies and Reagents We used the following antibodies and reagents: phos- pho–NF- B/p65 (Ser536) (1:500, 3031; Cell Signaling, Inc, Bevrly, MA), NF- B p65 (1:1,000, ab7970; Abcam, Inc, Cambridge, A), PTEN (1:300, 9559; Cell Signaling, Inc), PPP2CA (1:1000, A300307; Origene, Rockville, MD), SOCS1 (1:750, sc-9021; anta Cruz Biotech, Inc, Santa Cruz, CA), -actin (1:1000, 30065; Santa Cruz Biotech, Inc), BAY-117082 (cat no. 196870; albiochem, Darmstadt, Germany), and NT (cat. no 048-03; hoenixBiotech, Inc, Jamestown, NY).

Techniques: Binding Assay, Luciferase, Activity Assay, Transfection, Western Blot, Phospho-proteomics, Enzyme-linked Immunosorbent Assay

Figure 6. NT affects the tumorigenicity and invasiveness of colon cancer cells through regulation of miR-21 and miR-155 pathways. (A) Number of colonies and (B) invading cells in NT-treated HCT116, DLD1, and SW480 cells in which miR-21 and/or miR-155 were knocked down. (C) NT effects on tumor volume in a HCT116-xenograft model described in the Materials and Methods section. The P value indicates differences between NT/as-miR-NC–treated mice vs NT/as-miR-21/as-miR-155–treated mice. (D) PTEN, SOCS1, and PPP2CA mRNA levels in NT-treated HCT-116- xenograft tumors (day 35).

Journal: Gastroenterology

Article Title: Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

doi: 10.1053/j.gastro.2011.07.038

Figure Lengend Snippet: Figure 6. NT affects the tumorigenicity and invasiveness of colon cancer cells through regulation of miR-21 and miR-155 pathways. (A) Number of colonies and (B) invading cells in NT-treated HCT116, DLD1, and SW480 cells in which miR-21 and/or miR-155 were knocked down. (C) NT effects on tumor volume in a HCT116-xenograft model described in the Materials and Methods section. The P value indicates differences between NT/as-miR-NC–treated mice vs NT/as-miR-21/as-miR-155–treated mice. (D) PTEN, SOCS1, and PPP2CA mRNA levels in NT-treated HCT-116- xenograft tumors (day 35).

Article Snippet: Materials and Methods Antibodies and Reagents We used the following antibodies and reagents: phos- pho–NF- B/p65 (Ser536) (1:500, 3031; Cell Signaling, Inc, Bevrly, MA), NF- B p65 (1:1,000, ab7970; Abcam, Inc, Cambridge, A), PTEN (1:300, 9559; Cell Signaling, Inc), PPP2CA (1:1000, A300307; Origene, Rockville, MD), SOCS1 (1:750, sc-9021; anta Cruz Biotech, Inc, Santa Cruz, CA), -actin (1:1000, 30065; Santa Cruz Biotech, Inc), BAY-117082 (cat no. 196870; albiochem, Darmstadt, Germany), and NT (cat. no 048-03; hoenixBiotech, Inc, Jamestown, NY).

Techniques: